XML 79 R37.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2019
Income Tax Disclosure [Abstract]  
Schedule of Income (Loss) before Income Taxes
For financial reporting purposes, income (loss) before income taxes includes the following components:
 
 
Years Ended December 31,
(in thousands)
 
2019
 
2018
 
2017
United States
 
$
(393,955
)
 
$
(309,183
)
 
$
(440,696
)
Foreign
 
38,045

 
(39,906
)
 
(8,425
)
Total
 
$
(355,910
)
 
$
(349,089
)
 
$
(449,121
)

Schedule of Income Tax Expense (Benefit)
Following were the components of income tax expense (benefit) for the years ended December 31, 2019, 2018, and 2017:
(in thousands)
 
2019
 
2018
 
2017
Current
 
 
 
 
 
 
Federal
 
$

 
$

 
$

State
 

 
6

 
9

Foreign
 
2,877

 
(100
)
 
2,276

Deferred
 
 
 
 
 
 
Federal
 
(984
)
 

 
(150,015
)
State
 
(1,415
)
 

 
(17,389
)
Foreign
 

 

 

Total
 
$
478

 
$
(94
)
 
$
(165,119
)

Schedule of Reconciliation of the Statutory Tax Rates and the Effective Tax Rates
A reconciliation of the statutory tax rates and the effective tax rates for the years ended December 31, 2019, 2018 and 2017 are as follows:
 
 
Years Ended
December 31,
 
 
2019
 
2018
 
2017
Statutory rate
 
(21
)%
 
(21
)%
 
(34
)%
State taxes, net of federal benefit
 

 
(4
)
 
(5
)
Nondeductible IPR&D
 

 
6

 
(1
)
Contingent consideration
 

 
1

 
(18
)
Tax credits
 
(16
)
 
(10
)
 
(2
)
Foreign income tax rate differential
 
9

 
2

 
5

Impact of 2017 Act
 

 

 
27

Nondeductible debt conversion
 
(1
)
 

 

Other
 

 

 
5

Valuation allowance
 
29

 
26

 
(14
)
Net
 
 %
 
 %
 
(37
)%

Schedule of Significant Components of the Deferred Tax Assets and Liabilities The significant components of the deferred tax assets and liabilities are as follows:
 
 
For Years Ended
December 31,
(in thousands)
 
2019
 
2018
Deferred tax assets
 
 
 
 
Intellectual property
 
$
46,521

 
$
48,339

Amortization/depreciation
 
2,329

 
3,732

Research tax credit
 
141,669

 
96,509

Net operating loss carry forwards
 
286,850

 
248,398

Deferred reimbursement
 
2,230

 
4,401

Non-cash stock issue
 
19,058

 
16,850

Interest carry forward limitation
 
2,224

 
1,032

Other
 
15,986

 
10,852

Gross deferred tax assets
 
516,867

 
430,113

Deferred tax liabilities
 
 
 
 
Business acquisition
 
(5,051
)
 
(6,465
)
Royalty payable
 
(46,521
)
 
(48,339
)
Convertible notes
 
(653
)
 
(16,666
)
Advanced R&D payments
 
(2,611
)
 
(2,103
)
Other
 
(725
)
 

Total net deferred tax assets
 
461,306

 
356,540

Less: valuation allowance
 
(466,357
)
 
(363,005
)
Net deferred tax liability
 
$
(5,051
)
 
$
(6,465
)